Prospective Analysis of Lipid Variations in Hyperthyroid Subjects from Lahore, Pakistan

被引:1
作者
Iqbal, Muhammad Amir [1 ]
Ahmad, Shaaf [2 ]
Mumtaz, Tamseela [1 ,3 ]
Naseem, Zahra [1 ]
Malik, Javeria [1 ]
Ahmad, Husna [1 ]
Roohi, Nabila [1 ]
机构
[1] Univ Punjab, Inst Zool, Canal Rd, Lahore 54590, Punjab, Pakistan
[2] King Edward Med Univ, Mayo Hosp, Hosp Rd, Lahore 54000, Punjab, Pakistan
[3] Govt Coll Women Univ, Dept Zool, Faisalabad, Punjab, Pakistan
关键词
D O I
10.1155/2021/9936782
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Perturbations in the actions of T-3 and T-4 influence the normal metabolic pathways. Responsiveness of lipid biomarkers like LDL-C, HDL-C, TC, TG, Apo-A, and Apo-B after rehabilitation of thyroid profile attaining euthyroid state was determined. A total of 179 age-matched subjects of both genders were recruited for this research. Sixty healthy controls, thirty-four subclinical, fifty overt hyperthyroid, and thirty-five follow-up subjects having 3 months of Carbimazole therapy were enrolled. Biochemical analysis was performed by chemistry analyzer, RIA, and ELISA. One-way ANOVA was applied for the statistical analysis, while significance (P < 0.05) of means was compared by the Student-Newman-Keuls (SNK) test. Pronounced reduction (P < 0.001) of cholesterol in overt as compared to control and subclinical was noticed, whereas marked improvement (P < 0.001) was evidenced in follow-up. Prominent elevation (P < 0.05) of TG in follow-up was evidenced as compared to control. Overt presented marked reduction of HDL-C as compared to subclinical and control (P < 0.01 and P < 0.001), respectively. Pronounced elevation (P < 0.001) of HDL-C was evidenced after treatment. Overt presented reduction of LDL-C as compared to subclinical and control (P < 0.01 and P < 0.05, respectively). The follow-up group demonstrated considerable (P < 0.001) improvement of LDL-C after treatment and elevation (P < 0.05) as compared to control. Overt presented reduction of Apo-B as compared to subclinical and control (P < 0.05 and P < 0.001, respectively). Improvement (P < 0.05) of Apo-B was evidenced in follow-up. Reduction (P < 0.05) of Apo-A in overt as compared to control and elevation (P < 0.05) in follow-up as compared to overt was evidenced. Conclusively, improvement after treatment was evidenced in lipid profile.
引用
收藏
页数:9
相关论文
共 68 条
  • [61] Thyroid Screening During Early Pregnancy and the Need for Trimester Specific Reference Ranges: A Cross-Sectional Study in Lahore, Pakistan
    Talat, Afnan
    Khan, Aleena A.
    Nasreen, Samia
    Wass, John A.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [62] TALL AR, 1993, J LIPID RES, V34, P1255
  • [63] Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men
    Talmud, PJ
    Hawe, E
    Miller, GJ
    Humphries, SE
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (11) : 1918 - 1923
  • [64] Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: Roles of hepatic lipase and cholesteryl ester transfer protein
    Tan, KCB
    Shiu, SWM
    Kung, AWC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) : 2921 - 2924
  • [65] Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein AI promoter
    Taylor, AH
    Wishart, P
    Lawless, DE
    Raymond, J
    Wong, NCW
    [J]. BIOCHEMISTRY, 1996, 35 (25) : 8281 - 8288
  • [66] Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
    Vaisar, Tomas
    Pennathur, Subramaniam
    Green, Pattie S.
    Gharib, Sina A.
    Hoofnagle, Andrew N.
    Cheung, Marian C.
    Byun, Jaeman
    Vuletic, Simona
    Kassim, Sean
    Singh, Pragya
    Chea, Helen
    Knopp, Robert H.
    Brunzell, John
    Geary, Randolph
    Chait, Alan
    Zhao, Xue-Qiao
    Elkon, Keith
    Marcovina, Santica
    Ridker, Paul
    Oram, John F.
    Heinecke, Jay W.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) : 746 - 756
  • [67] HYPOCHOLESTEROLEMIA IN CLINICALLY SERIOUS CONDITIONS - REVIEW
    Vyroubal, Pavel
    Chiarla, Carlo
    Giovannini, Ivo
    Hyspler, Radek
    Ticha, Alena
    Hrnciarikova, Dana
    Zadak, Zdenek
    [J]. BIOMEDICAL PAPERS-OLOMOUC, 2008, 152 (02): : 181 - 189
  • [68] Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy
    Walldius, G
    Jungner, I
    [J]. JOURNAL OF INTERNAL MEDICINE, 2004, 255 (02) : 188 - 205